Seasonal influenza vaccines: Variability of immune responses to B lineage viruses. [PDF]
Miller MS+6 more
europepmc +1 more source
Recombinants of influenza virus type B as potential live vaccine candidates: RNA characterization and evaluation in man [PDF]
M. Lobmann+3 more
openalex +1 more source
Sequential infection or immunization of ferrets with a series of influenza A (H3N2) strains (Report to the Medical Research Council's Sub-Committee on Influenza Vaccines (CDVIP/IV)) [PDF]
C. W. Potter+5 more
openalex +1 more source
The Amur tiger, an endangered flagship species mainly found in the Russia Far East and Northeastern China, holds immense biological importance, and has been listed under the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES).
Wei Xie+15 more
wiley +1 more source
Boosting neuraminidase immunity in the presence of hemagglutinin with the next generation of influenza vaccines. [PDF]
Cortés G+17 more
europepmc +1 more source
Studies on influenza vaccine in industry
J. W. G. Smith, Richard B. Pollard
openalex +1 more source
Response of seronegative and seropositive adult volunteers to live attenuated cold-adapted reassortant influenza A virus vaccine [PDF]
M L Clements, E L Tierney, B R Murphy
openalex +1 more source
Political Affiliation, Policy Measures, and Intention to Receive COVID-19 and Influenza Vaccines. [PDF]
Ricke IJ+4 more
europepmc +1 more source
Has COVID‐19 vaccination success increased the marginal willingness to pay taxes?
Abstract The COVID‐19 vaccination campaign can be regarded as a public‐sector success story. Given the shock caused by the pandemic, the highly visible and successful response of the public authorities in rolling out the vaccination might have elicited an increase in public trust.
José María Durán‐Cabré+3 more
wiley +1 more source
Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccines. [PDF]
Hauguel T+28 more
europepmc +1 more source